Shattuck Labs (STTK) Research & Development (2019 - 2026)
Shattuck Labs (STTK) posted quarterly Research & Development of $10.9 million for Q1 2026, up 10.35% year-over-year from $9.9 million in Q1 2025, and up 20.88% quarter-over-quarter from $9.1 million in Q4 2025.
Shattuck Labs (STTK) Research & Development (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has reported Research & Development for 8 consecutive years, with $10.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Research & Development rose 10.35% year-over-year to $10.9 million; the TTM figure through Mar 2026 stood at $36.3 million (down 40.36% YoY), while the FY2025 annual figure was $35.3 million, down 47.52% from the prior year.
- Research & Development advanced to $10.9 million in Q1 2026 per STTK's latest filing, from $9.1 million in the prior quarter.
- Across five years, Research & Development topped out at $24.2 million in Q3 2023 and bottomed at $7.6 million in Q3 2025.
- Historically, Research & Development has averaged $15.9 million across 5 years, with a median of $16.3 million in 2024.
- Annual changes were most pronounced in 2022 — Research & Development jumped 85.61% — and 2025, when it slumped 54.88%.
- Shattuck Labs' Research & Development stood at $21.9 million in 2022, then sank by 30.43% to $15.2 million in 2023, then rose by 1.1% to $15.4 million in 2024, then sank by 41.18% to $9.1 million in 2025, then rose by 20.88% to $10.9 million in 2026.
- Business Quant data shows STTK's Research & Development at $10.9 million in Q1 2026, $9.1 million in Q4 2025, and $7.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 993.80 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.63 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.37 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 394.92 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 612.28 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 1,146.05 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 97.90 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 413.13 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 210.03 Mn |
| 10 | Shattuck Labs | 962.96 Mn | 962.96 Mn | - | 11.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.70 Mn |
| Mar 31, 2026 | 10.95 Mn |
| Dec 31, 2025 | 9.06 Mn |
| Sep 30, 2025 | 7.62 Mn |
| Jun 30, 2025 | 8.68 Mn |
| Mar 31, 2025 | 9.92 Mn |
| Dec 31, 2024 | 15.40 Mn |
| Sep 30, 2024 | 16.31 Mn |
| Jun 30, 2024 | 19.24 Mn |
| Mar 31, 2024 | 16.26 Mn |
| Dec 31, 2023 | 15.23 Mn |
| Sep 30, 2023 | 24.21 Mn |
| Jun 30, 2023 | 18.21 Mn |
| Mar 31, 2023 | 16.67 Mn |
| Dec 31, 2022 | 21.89 Mn |
| Sep 30, 2022 | 18.86 Mn |
| Jun 30, 2022 | 22.96 Mn |
| Mar 31, 2022 | 19.19 Mn |
| Dec 31, 2021 | 16.21 Mn |
| Sep 30, 2021 | 15.14 Mn |